Allarity Therapeutics News

Allarity Therapeutics' Stenoparib Shows Promise in Ovarian Cancer Trial

TipRanks06:22 ET

Why Is Nano-Cap Allarity Therapeutics Stock Trading Up On Thursday?

Allarity Therapeutics Inc (NASDAQ:ALLR) shares are trading higher on a strong session volume of 67 million, as per the data from Benzinga Pro.The company announced the early discontinuation of its Pha

Benzinga12:29 ET

Nasdaq Jumps Over 100 Points; Kellanova Posts Upbeat Results

U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 100 points on Thursday.Following the market opening Thursday, the Dow traded up 0.48% to 38,085.28 while the NASDAQ rose

BenzingaMay 2 09:52 ET

Wall Street Set to Open Higher Thursday After Fed Holds Rate Steady, Jobless Claims Lower Than Expected

US stocks look set to open higher in Thursday's trading session following the Federal Reserve's decision to leave rates unchanged Wednesday, and after jobless claims came in lower than expected earlie

MT NewswiresMay 2 09:23 ET

Market-Moving News May 2nd

ALLR: 151% | Allarity Therapeutics shares are trading higher after the company announced that Stenoparib shows a clear clinical benefit, leading to early conclusion of the Phase 2 trial in advanced ov

BenzingaMay 2 08:39 ET

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersAllarity Therapeutics (NASDAQ:ALLR) stock moved upwards by 106.6% to $2.83 during Thursday's pre-market session. The market value of their outstanding shares is at $5.5 million. Emergent BioSol

BenzingaMay 2 08:06 ET

Express News | Allarity Therapeutics Shares Are Trading Higher After the Company Announced That Stenoparib Shows a Clear Clinical Benefit, Leading to Early Conclusion of the Phase 2 Trial in Advanced Ovarian Cancer

BenzingaMay 2 08:04 ET

Express News | Allarity Therapeutics Announces Stenoparib Shows Clear Clinical Benefit, Co. Announces Early Conclusion Of Phase 2 Trial In Advanced Ovarian Cancer

BenzingaMay 2 08:03 ET

Express News | Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone With Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

ReutersMay 2 08:00 ET

Allarity Therapeutics Maintains NASDAQ Compliance With Bid Price

TipRanksApr 30 08:23 ET

Express News | Allarity Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

ReutersApr 29 07:00 ET

12 Health Care Stocks Moving In Monday's After-Market Session

GainersNuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million. Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 7.42% to

BenzingaApr 22 16:31 ET

Predictive Oncology, BIMI Holdings, IMAC Holdings Among Healthcare Movers

Seeking AlphaApr 19 10:00 ET

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 9.0% to $4.58 during Thursday's after-market session. The company's market cap stands at $3.4 million. Biora Therapeutics (NASDAQ:BIOR) share

BenzingaApr 18 16:31 ET

Allarity Therapeutics Granted Extension for Nasdaq Compliance

TipRanksApr 18 07:12 ET

Allarity Therapeutics Offering 5M Shrs at Assumed Public Offering Price of $2 Each

Allarity Therapeutics Offering 5M Shrs at Assumed Public Offering Price of $2 Each

Dow JonesApr 17 09:28 ET

Express News | Allarity Therapeutics Receives Extension To Regain Compliance With Nasdaq

Moomoo 24/7Apr 17 09:11 ET

Express News | Allarity Therapeutics Receives Nasdaq-Approved Extension to Regain Compliance With Nasdaq Listing Rule 5550(B)(1)

Moomoo 24/7Apr 17 09:10 ET

WIRE, CUTR and USEG Are Among Premarket Gainers

Seeking AlphaApr 15 08:41 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

GainersSoligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Longeveron (NASDAQ:LGVN) shares increased by 51.47

BenzingaApr 15 08:07 ET